Gross to Net Finance Lead
argenxBoston, Massachusetts, United States
Posted November 7, 2025
176000 - 264000 USD year
Full Time
About the Company
argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.
Job Description
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business.
Requirements
- Develop the Managed Market Team's vision and long-term goals
- Own and collaborate cross-functionally with commercial leaders, market access, FP&A, 3PL partners and legal on new products, contract analysis, government policies assessing impacts to revenue recognition
- Manage the month-end revenue close process for US product sales
- Manage order to cash, working collaboratively with 3PL to ensure payments are received timely and AR is reflective of the most accurate balance
- Coordinate with internal and external auditors during quarterly reviews and annual audits
- Partner with Market Access in reviewing all payor contracts
Benefits
- Short-term and long-term incentive programs
- Comprehensive benefits package
- Retirement savings plans
- Health benefits
